EU: Cluster Gesundheit in Horizon Europe 2023

Horizont Europa ist das Förderprogramm der Europäischen Union für Forschung und Innovation. Es bietet eine Vielzahl verschiedener Fördermöglichkeiten, unter anderem im Rahmen des Clusters Gesundheit (Health).

Im Arbeitsprogramm 2023-2024 des Clusters Gesundheit finden sich die konkreten Themen und Fristen, zu denen Anträge eingereicht werden können. Die nächste Antragsfrist ist der 13. April 2023. Es handelt sich hier ausschließlich um einstufige Verfahren, d.h. es wird direkt ein Vollantrag eingereicht. Eine Antragseinreichung ist ab dem 12. Januar 2023 möglich.

Bis zu dieser Frist ist die Antragseinreichung für folgende Themen für Research and Innovation Actions möglich:

• HORIZON-HLTH-2023-STAYHLTH-01-01-single-stage: The Silver Deal – Person-centred health and care in European regions (RIA)
• HORIZON-HLTH-2023-ENVHLTH-02-01-single stage: Planetary health: understanding the links between environmental degradation and health impacts (RIA)
• HORIZON-HLTH-2023-ENVHLTH-02-02-single stage: Evidence-based interventions for promotion of mental and physical health in changing working environments (post-pandemic workplaces) (RIA)
• HORIZON-HLTH-2023-ENVHLTH-02-03-single stage: Health impacts of endocrine-disrupting chemicals: bridging science-policy gaps by addressing persistent scientific uncertainties (RIA)
• HORIZON-HLTH-2023-ENVHLTH-02-04-single stage: Global coordination of exposome research (CSA)
• HORIZON-HLTH-2023-DISEASE-03-01-single-stage: Novel approaches for palliative and end-of-life care for non-cancer patients (RIA)
• HORIZON-HLTH-2023-DISEASE-03-03-single-stage: Interventions in city environments to reduce risk of non-communicable disease (Global Alliance for Chronic Diseases – GACD) (RIA)
• HORIZON-HLTH-2023-DISEASE-03-04-single-stage: Pandemic preparedness and response: Broad spectrum anti-viral therapeutics for infectious diseases with epidemic potential (RIA)
• HORIZON-HLTH-2023-DISEASE-03-07-single-stage: Relationship between infections and non-communicable diseases (RIA)
• HORIZON-HLTH-2023-DISEASE-03-17-single-stage: Pandemic preparedness and response: Understanding vaccine induced-immunity (RIA)
• HORIZON-HLTH-2023-DISEASE-03-18-single-stage: Pandemic preparedness and response: Immunogenicity of viral proteins of viruses with epidemic and pandemic potential (RIA)
• HORIZON-HLTH-2023-CARE-04-01-single-stage: Maintaining access to regular health and care services in case of cross-border emergencies (RIA)
• HORIZON-HLTH-2023-CARE-04-02-single-stage: Resilience and mental wellbeing of the health and care workforce (RIA)
• HORIZON-HLTH-2023-CARE-04-03-single-stage: Environmentally sustainable and climate neutral health and care systems (RIA)
• HORIZON-HLTH-2023-TOOL-05-01-single-stage: Clinical trials of combined Advanced Therapy Medicinal Products (ATMPs) (RIA)
• HORIZON-HLTH-2023-TOOL-05-03-single-stage: Integrated, multi-scale computational models of patient patho-physiology (‘virtual twins’) for personalised disease management (RIA)
• HORIZON-HLTH-2023-TOOL-05-04-single-stage: Better integration and use of health-related real-world and research data, including genomics, for improved clinical outcomes (RIA)
• HORIZON-HLTH-2023-TOOL-05-05-single-stage: Harnessing the potential of real-time data analysis and secure Point-of-Care computing for the benefit of person-centred health and care delivery (IA)
• HORIZON-HLTH-2023-TOOL-05-08-single-stage: Pandemic preparedness and response: In vitro diagnostic devices to tackle cross-border health threats (IA)
• HORIZON-HLTH-2023-IND-06-02-single-stage: Expanding the European Electronic Health Record exchange Format to improve interoperability within the European Health Data Space (RIA)
• HORIZON-HLTH-2023-IND-06-04-single-stage: Modelling and simulation to address regulatory needs in the development of orphan and paediatric medicines (RIA)
• HORIZON-HLTH-2023-IND-06-07-single-stage: Development and harmonisation of methodologies for assessing digital health technologies in Europe (RIA)